Patents by Inventor Igor D Grachev

Igor D Grachev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF PRIDOPIDINE FOR TREATING DYSTONIAS
    Publication number: 20240075021
    Abstract: The invention provides a method of treating a subject afflicted with a dystonia, comprising periodically administering to the subject a pharmaceutical composition comprising an amount of pridopidine effective to treat the subject.
    Type: Application
    Filed: October 19, 2023
    Publication date: March 7, 2024
    Applicant: Prilenia Neurotherapeutics Ltd.
    Inventors: Michael HAYDEN, Spyridon PAPAPETROPOULOS, Juha-Matti SAVOLA, Eli EYAL, Beth BOROWSKY, Igor D. GRACHEV, Mark Forrest GORDON
  • Use of pridopidine for treating dystonias
    Patent number: 11826361
    Abstract: The invention provides a method of treating a subject afflicted with a dystonia, comprising periodically administering to the subject a pharmaceutical composition comprising an amount of pridopidine effective to treat the subject.
    Type: Grant
    Filed: February 24, 2019
    Date of Patent: November 28, 2023
    Assignee: PRILENIA NEUROTHERAPEUTICS LTD
    Inventors: Michael Hayden, Spyridon Papapetropoulos, Juha-Matti Savola, Eli Eyal, Beth Borowsky, Igor D. Grachev, Mark Forrest Gordon
  • USE OF PRIDOPIDINE FOR TREATING DYSTONIAS
    Publication number: 20190192496
    Abstract: The invention provides a method of treating a subject afflicted with a dystonia, comprising periodically administering to the subject a pharmaceutical composition comprising an amount of pridopidine effective to treat the subject.
    Type: Application
    Filed: February 24, 2019
    Publication date: June 27, 2019
    Applicant: PRILENIA THERAPEUTICS DEVELOPMENT LTD.
    Inventors: Michael HAYDEN, Spyridon PAPAPETROPOULOS, Juha-Matti SAVOLA, Eli EYAL, Beth BOROWSKY, Igor D. GRACHEV, Mark Forrest GORDON
  • USE OF PRIDOPIDINE FOR TREATING FUNCTIONAL DECLINE
    Publication number: 20180055832
    Abstract: This invention provides a method of maintaining functional capacity, improving functional capacity, or lessening the decline of functional capacity in a human patient comprising periodically orally administering to the patient a pharmaceutical composition comprising pridopidine such that a dose of 90-225 mg of pridopidine is administered to the patient per day, so as to thereby maintain functional capacity, improve functional capacity, or lessen the decline of functional capacity in the human patient.
    Type: Application
    Filed: August 24, 2017
    Publication date: March 1, 2018
    Applicant: Teva Pharmaceuticals International GmbH
    Inventors: Michael Hayden, Spyridon Papapetropoulos, Juha-Matti Savola, Eli Eyal, Beth Borowsky, Igor D Grachev